EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Fungal sinusitis due to mucormycosis in a diabetic immunosuppressed patient with acute myeloid leukemia (AML)

Gulfem Ece, Ejder Ciger, Celal Acar, Seckin Cagirgan, Ogulcan Cetin

The Journal of Infection in Developing Countries · 2024

DOI: 10.3855/jidc.19724 ↗

Kurz gefasst

Fallbericht in der Zeitschrift The Journal of Infection in Developing Countries, 2024. Verfasst von Gulfem Ece und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Microbiology, Izmir City Hospital, Izmir, Turkiye. Hauptthemen laut MEDLINE: Mucormycosis, Leukemia, Myeloid, Acute, Immunocompromised Host, Sinusitis. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Mucormycosis is an acute onset, invasive, fungal infection, characterized by organ involvement, and caused by Mucor, Rhizopus, or Absidia. Our aim was to present a case of mucormycotic infection and emphasize its importance in a diabetic immunosuppressed patient with acute myeloid leukemia (AML). Case presentation: A 68-year-old hypertensive and diabetic male patient with a diagnosis of AML developed respiratory failure and exhibited diffuse bilateral consolidation in high-resolution computed tomography (HRCT). The treatment plan involved chemotherapy with cytarabine (200 mg/m2/day for 7 days) and daunorubicin (60 mg/m2/day for 3 days) starting on 20 July 2022. Posaconazole prophylactic treatment was initiated on 23 July 2022, to prevent fungal infections. Five days later there was a black necrotic appearance on the left wing of the nose. The patient underwent excision of the left wing of the nose. Mucor was detected in the excision tissue both histopathologically and in culture. A culture under lactophenol cotton blue (LFCB) staining displaying hyphal structures of Mucor was obtained. The patient died of progressive pneumonia and sepsis.

Conclusions

Mucormycosis is an infection with high mortality, and should be considered in the early stages of diagnosis when dealing with immunosuppression patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MucormycosisLeukemia, Myeloid, AcuteImmunocompromised HostSinusitisHumansMaleAgedFatal OutcomeAntifungal AgentsMucorDiabetes ComplicationsTriazoles

Stichwörter der Autor:innen

AMLMucordiabetes mellitusfungal sinusitis

Substanzen

Antifungal AgentsposaconazoleTriazoles

Autor:innen und Institutionen

  • Department of Medical Microbiology, Izmir City Hospital, Izmir, Turkiye.
  • Department of Ear Nose and Throat, Tepecik Education and Research Hospital, Izmir, Turkiye.
  • Department of Hematology, Izmir University of Economics School of Medicine, Medical Point Izmir Hospital, Izmir, Turkiye.
  • Izmir City Hospital, Izmir, Turkiye.

Zitieren

APA

Ece, G., Ciger, E., Acar, C., Cagirgan, S., & Cetin, O. (2024). Fungal sinusitis due to mucormycosis in a diabetic immunosuppressed patient with acute myeloid leukemia (AML). The Journal of Infection in Developing Countries. https://doi.org/10.3855/jidc.19724

Vancouver

Ece G, Ciger E, Acar C, Cagirgan S, Cetin O. Fungal sinusitis due to mucormycosis in a diabetic immunosuppressed patient with acute myeloid leukemia (AML). The Journal of Infection in Developing Countries. 2024. doi:10.3855/jidc.19724

BibTeX
@article{Ece2024,
  author = {Ece, Gulfem and Ciger, Ejder and Acar, Celal and Cagirgan, Seckin and Cetin, Ogulcan},
  title = {Fungal sinusitis due to mucormycosis in a diabetic immunosuppressed patient with acute myeloid leukemia (AML)},
  journal = {The Journal of Infection in Developing Countries},
  year = {2024},
  doi = {10.3855/jidc.19724}
}
Kostenlos starten →